382 related articles for article (PubMed ID: 27443648)
1. Chemotherapy-Related Neurotoxicity.
Taillibert S; Le Rhun E; Chamberlain MC
Curr Neurol Neurosci Rep; 2016 Sep; 16(9):81. PubMed ID: 27443648
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Curr Opin Neurol; 2015 Oct; 28(5):500-7. PubMed ID: 26197027
[TBL] [Abstract][Full Text] [Related]
3. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
4. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
[TBL] [Abstract][Full Text] [Related]
5. Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity.
Alberti P; Cavaletti G; Cornblath DR
Curr Opin Neurol; 2019 Oct; 32(5):676-683. PubMed ID: 31306214
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.
Cavaletti G
J Peripher Nerv Syst; 2014 Jun; 19(2):66-76. PubMed ID: 24976572
[TBL] [Abstract][Full Text] [Related]
7. Pediatric chemotherapy induced peripheral neuropathy: A systematic review of current knowledge.
Kandula T; Park SB; Cohn RJ; Krishnan AV; Farrar MA
Cancer Treat Rev; 2016 Nov; 50():118-128. PubMed ID: 27664395
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
Gewandter JS; Kleckner AS; Marshall JH; Brown JS; Curtis LH; Bautista J; Dworkin RH; Kleckner IR; Kolb N; Mohile SG; Mustian KM
Support Care Cancer; 2020 Jun; 28(6):2553-2562. PubMed ID: 31494735
[TBL] [Abstract][Full Text] [Related]
9. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey.
McCrary JM; Goldstein D; Boyle F; Cox K; Grimison P; Kiernan MC; Krishnan AV; Lewis CR; Webber K; Baron-Hay S; Horvath L; Park SB;
Support Care Cancer; 2017 Nov; 25(11):3485-3493. PubMed ID: 28589310
[TBL] [Abstract][Full Text] [Related]
10. Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience.
Velasco R; Besora S; Argyriou AA; Santos C; Sala R; Izquierdo C; Simó M; Gil-Gil M; Pardo B; Jiménez L; Clapés V; Calvo M; Palmero R; Bruna J
Anticancer Drugs; 2021 Jan; 32(1):88-94. PubMed ID: 33332891
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-Induced Peripheral Neurotoxicity assessment: a critical revision of the currently available tools.
Cavaletti G; Frigeni B; Lanzani F; Mattavelli L; Susani E; Alberti P; Cortinovis D; Bidoli P
Eur J Cancer; 2010 Feb; 46(3):479-94. PubMed ID: 20045310
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy-induced peripheral neuropathy: A current review.
Staff NP; Grisold A; Grisold W; Windebank AJ
Ann Neurol; 2017 Jun; 81(6):772-781. PubMed ID: 28486769
[TBL] [Abstract][Full Text] [Related]
13. Cerebral Perfusion and Gray Matter Changes Associated With Chemotherapy-Induced Peripheral Neuropathy.
Nudelman KN; McDonald BC; Wang Y; Smith DJ; West JD; O'Neill DP; Zanville NR; Champion VL; Schneider BP; Saykin AJ
J Clin Oncol; 2016 Mar; 34(7):677-83. PubMed ID: 26527786
[TBL] [Abstract][Full Text] [Related]
14. Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy.
Lees JG; Makker PG; Tonkin RS; Abdulla M; Park SB; Goldstein D; Moalem-Taylor G
Eur J Cancer; 2017 Mar; 73():22-29. PubMed ID: 28104535
[TBL] [Abstract][Full Text] [Related]
15. Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy.
Smith EM; Campbell G; Tofthagen C; Kottschade L; Collins ML; Warton C; Ghosh B; Ronis DL; Mallory GA; Visovsky C
Oncol Nurs Forum; 2014 Nov; 41(6):669-79. PubMed ID: 25355022
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy-induced peripheral neurotoxicity: management informed by pharmacogenetics.
Argyriou AA; Bruna J; Genazzani AA; Cavaletti G
Nat Rev Neurol; 2017 Aug; 13(8):492-504. PubMed ID: 28664909
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity?
Cavaletti G; Marmiroli P; Renn CL; Dorsey SG; Serra MP; Quartu M; Meregalli C
Neurotherapeutics; 2021 Oct; 18(4):2324-2336. PubMed ID: 34668147
[TBL] [Abstract][Full Text] [Related]
18. Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.
Loprinzi CL; Lacchetti C; Bleeker J; Cavaletti G; Chauhan C; Hertz DL; Kelley MR; Lavino A; Lustberg MB; Paice JA; Schneider BP; Lavoie Smith EM; Smith ML; Smith TJ; Wagner-Johnston N; Hershman DL
J Clin Oncol; 2020 Oct; 38(28):3325-3348. PubMed ID: 32663120
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-induced neuropathy: A comprehensive survey.
Miltenburg NC; Boogerd W
Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
[TBL] [Abstract][Full Text] [Related]
20. [Neurotoxicity and dermatologic toxicity of cancer chemotherapy].
Nakane M
Gan To Kagaku Ryoho; 2006 Jan; 33(1):29-33. PubMed ID: 16410694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
